RVL Pharmaceuticals plc Quarterly Goodwill in USD from Q4 2016 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.
Summary
RVL Pharmaceuticals plc quarterly Goodwill history and growth rate from Q4 2016 to Q2 2023.
  • RVL Pharmaceuticals plc Goodwill for the quarter ending June 30, 2023 was $55.8M, unchanged year-over-year.
Goodwill, Quarterly (USD)
Goodwill, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2023 $55.8M $0 0% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 $55.8M $0 0% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $55.8M $0 0% Dec 31, 2022 10-Q 2023-08-14
Q3 2022 $55.8M $0 0% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $55.8M $0 0% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $55.8M -$45M -44.6% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $55.8M $0 0% Dec 31, 2021 10-K 2023-03-20
Q3 2021 $55.8M -$45M -44.6% Sep 30, 2021 10-Q 2021-11-15
Q2 2021 $55.8M -$45M -44.6% Jun 30, 2021 10-Q 2021-08-16
Q1 2021 $101M $0 0% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $55.8M $0 0% Dec 31, 2020 10-K 2023-03-20
Q3 2020 $101M +$184 0% Sep 30, 2020 10-Q 2020-11-10
Q2 2020 $101M +$184 0% Jun 30, 2020 10-Q 2020-08-11
Q1 2020 $101M +$184 0% Mar 31, 2020 10-Q 2020-05-12
Q4 2019 $55.8M $0 0% Dec 31, 2019 10-K 2022-03-30
Q3 2019 $101M -$86.3M -46.1% Sep 30, 2019 10-Q 2019-11-14
Q2 2019 $101M Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $101M Mar 31, 2019 10-Q 2019-05-09
Q4 2018 $55.8M -$131M -70.2% Dec 31, 2018 8-K 2021-09-08
Q3 2018 $187M Sep 30, 2018 10-K 2019-03-28
Q4 2017 $187M +$184 0% Dec 31, 2017 10-K 2020-03-19
Q4 2016 $187M Dec 31, 2016 8-K 2019-12-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.